Research, Science & development
-
Australian researchers develop world-first rapid diagnostic for iron deficiency
The test is now being evaluated for use in Sub-Saharan Africa, where researchers hope it could become the first validated rapid diagnostic test for iron deficiency.
-
Mayo Clinic study uncovers mechanism behind resistance to HER2 breast cancer drug
The researchers say the finding could help guide the development of more targeted treatment combinations for patients whose tumors produce the protein.
-
AusperBio begins patient dosing in trial of Hepatitis B siRNA candidate AHB-171
The latest milestone advances the company’s second clinical-stage therapeutic candidate and marks the first clinical programme built using its proprietary Au-HALO™ liver-targeting delivery technology and siRNA platform.
-
Amylyx launches PBH education site ahead of avexitide phase 3 results
Amylyx developed the education initiative after researching the PBH patient community.
-
Tel Aviv Sourasky Medical Center launches first global clinical trial of Silexion’s KRAS-targeting therapy for pancreatic cancer
The clinical trial will assess SIL204, an investigational treatment developed by Silexion using small interfering RNA (siRNA) technology.
-
Oxford begins human trials for the experimental Bundibugyo Ebola vaccine
The experimental vaccine was developed by scientists at the University of Oxford using the same vaccine technology employed in the Oxford-AstraZeneca COVID-19 vaccine.
-
Sidra Medicine research shows maternal diet shapes child health through epigenetics
Researchers found that women who delivered prematurely consumed significantly lower amounts of protein, vitamins and essential minerals than those who carried their pregnancies to term.
-
NYU Abu Dhabi researchers uncover hidden vulnerability in malaria parasite
This highly specific dependence could provide an opportunity for researchers to investigate new approaches to malaria treatment by targeting the parasite’s ability to obtain or use these fats.
-
Gilead, Merck present pivotal Phase 3 Islend data for first once-weekly oral HIV regimen
Researchers presented the findings at the 26th International AIDS Conference in Rio de Janeiro, Brazil.
-
Evogene collaborates with Blavatnik Center to advance Israeli biotech ecosystem
Under the agreement, researchers will gain access to an integrated platform that combines Evogene’s AI-powered computational chemistry engine, ChemPass AI, with the BCDD’s laboratory infrastructure and drug discovery expertise.